Dare Bioscience receives NIH funding extension for preterm birth treatment

Go back to Dare Bioscience receives NIH funding extension for preterm birth treatment
(NASDAQ: DARE) Delayed: 2.11 --0 (-0%)
Previous Close $2.11    52 Week High
Open $2.11    52 Week Low
Day High $2.11    P/E N/A 
Day Low $2.11    EPS
Volume 488